written on 14.03.2014

Under fire, FDA chief Hamburg defends approval of pain pill Zohydro


As pharmacies began dispensing Zogenix&#39;s powerful new painkiller Zohydro this week, FDA Commissioner Margaret Hamburg found herself under increasing pressure to revoke her agency&#39;s approval of the drug and yank it off the market. But she&#39;s not about to cave in to the pressure, she told the U.S. Senate&#39;s Health, Education, Labor and Pensions Committee during a hearing on Thursday, according to <em>Reuters</em>.